CIG
NVO

Cairn Investment Group’s Novo Nordisk NVO Stock Holding History

Cairn Investment Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Sell
9,333
-75
-0.8% -$3.22K 0.2% 49
2026
Q1 		$346K Sell
9,408
-920
-9% -$43.6K 0.17% 51
2025
Q4 		$525K Hold
10,328
– – 0.25% 47
2025
Q3 		$573K Hold
10,328
– – 0.26% 46
2025
Q2 		$713K Buy
10,328
+446
+5% +$30.3K 0.37% 43
2025
Q1 		$686K Sell
9,882
-168
-2% -$13.9K 0.39% 42
2024
Q4 		$865K Sell
10,050
-8,700
-46% -$941K 0.51% 42
2024
Q3 		$2.23M Sell
18,750
-200
-1% -$26.7K 1.23% 26
2024
Q2 		$2.71M Sell
18,950
-200
-1% -$26.5K 1.58% 26
2024
Q1 		$2.46M Sell
19,150
-30
-0.2% -$3.57K 1.41% 24
2023
Q4 		$1.98M Sell
19,180
-50
-0.3% -$4.95K 1.24% 24
2023
Q3 		$1.75M Sell
19,230
-100
-0.5% -$8.81K 1.16% 25
2023
Q2 		$1.56M Sell
19,330
-120
-0.6% -$9.8K 1.01% 27
2023
Q1 		$1.55M Sell
19,450
-17,000
-47% -$1.21M 1.08% 27
2022
Q4 		$2.47M Buy
36,450
+520
+1% +$30.5K 1.84% 18
2022
Q3 		$1.79M Sell
35,930
-1,270
-3% -$68K 1.45% 24
2022
Q2 		$2.07M Sell
37,200
-16,940
-31% -$940K 1.61% 23
2022
Q1 		$3.6M Hold
54,140
– – 2.28% 11
2021
Q4 		$3.03M Sell
54,140
-750
-1% -$40.6K 2.09% 11
2021
Q3 		$2.63M Sell
54,890
-700
-1% -$33.8K 1.95% 11
2021
Q2 		$2.33M Hold
55,590
– – 1.71% 18
2021
Q1 		$1.87M Sell
55,590
-370
-0.7% -$13.2K 1.56% 23
2020
Q4 		$1.95M Sell
55,960
-22,000
-28% -$760K 1.85% 18
2020
Q3 		$2.71M Sell
77,960
-4,290
-5% -$143K 2.87% 5
2020
Q2 		$2.69M Sell
82,250
-3,590
-4% -$115K 3.27% 3
2020
Q1 		$2.58M Buy
85,840
+30
+0% +$893 3.84% 3
2019
Q4 		$2.48M Buy
+85,810
New +$2.38M 2.46% 5

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cairn Investment Group's NVO Position: Q2 2026 in Review

Cairn Investment Group reduced its Novo Nordisk (NVO) stake by 0.8% in Q2 2026, selling an estimated $3.22K and leaving 9,333 shares worth $447K. The position accounts for 0.2% of the portfolio, ranked #49.

Cairn Investment Group first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.6M in Q1 2022. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cairn Investment Group held 9,333 shares of Novo Nordisk worth $447K as of Q2 2026.
  • Cairn Investment Group sold 75 Novo Nordisk shares in Q2 2026, an estimated $3.22K.
  • Novo Nordisk made up 0.2% of Cairn Investment Group's portfolio in Q2 2026, its #49 holding.
  • Cairn Investment Group first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
  • Cairn Investment Group's Novo Nordisk position peaked at $3.6M in Q1 2022.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cairn Investment Group's 13F filing for Q2 2026, filed 28 Jul 2026.